XPH icon

SPDR S&P Pharmaceuticals ETF

80 hedge funds and large institutions have $185M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 16 closing their positions.

Holders
80
Holders Change
+6
Holders Change %
+8.11%
% of All Funds
1.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
18
Reduced
21
Closed
16
Calls
$981K
Puts
Net Calls
+$981K
Net Calls Change
+$395K
Name Holding Trade Value Shares
Change
Shares
Change %
GWM
76
Geneos Wealth Management
Colorado
$4K
PA
77
Parallel Advisors
California
$2K
FRA
78
Front Row Advisors
California
$2K +$2K +44 New
GT
79
Glenmede Trust
Pennsylvania
$62 +$62 +1,500 New
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
-$7.62M -208,000 Closed
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
-$2.24M -61,079 Closed
VF
82
Virtu Financial
New York
-$1.09M -29,755 Closed
CCP
83
Corient Capital Partners
California
-$959K -26,183 Closed
Citadel Advisors
84
Citadel Advisors
Florida
-$560K -15,279 Closed
Renaissance Technologies
85
Renaissance Technologies
New York
-$315K -8,600 Closed
CCMD
86
Cypress Capital Management (Delaware)
Delaware
-$239K -6,540 Closed
BTS
87
BB&T Securities
Virginia
-$215K -5,893 Closed
EDRH
88
Edmond de Rothschild Holding
Switzerland
-$55K -1,500 Closed
BOPW
89
Brandywine Oak Private Wealth
Pennsylvania
-$22K -601 Closed
AIC
90
Ameritas Investment Company
Nebraska
-$13K -362 Closed
CF
91
Centaurus Financial
California
-$3 -102 Closed
CG
92
Cutler Group
California
-$3K -100 Closed
MPWT
93
MassMutual Private Wealth & Trust
Connecticut
-$3.66K -100 Closed
Simplex Trading
94
Simplex Trading
Illinois
-$3K -96 Closed
TFA
95
Transamerica Financial Advisors
Florida
-$1K -1 Closed